Home
Clinical Resources Search
PQI: Durvalumab (Imfinzi) Therapy Overview in Non-Small Cell Lung Cancer and Small Cell Lung Cancer

PQI: Durvalumab (Imfinzi) Therapy Overview in Non-Small Cell Lung Cancer and Small Cell Lung Cancer

Download PQI pdf

Last Updated: October 14, 2026

By: Joshua Nubla, PharmD

About this PQI

This PQI addresses the management of patients receiving durvalumab for Stage III unresectable non-small cell lung cancer (NSCLC) and first-line extensive-stage small cell lung cancer (ES-SCLC), including the management of immune-mediated adverse events.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

PQI: Durvalumab (Imfinzi) Therapy Overview in Non-Small Cell Lung Cancer and Small Cell Lung Cancer

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer

PQI: Cardiovascular Risk associated with Androgen Deprivation Therapy (ADT) in Prostate Cancer

PQI: Administration of Subcutaneous Isatuximab-irfc (SARCLISA ESCENA) via the CirCLIQ On-Body Delivery System

PQI: Relacorilant (LIFYORLI) and Albumin-Bound Paclitaxel (Nab-Paclitaxel) for Platinum-Resistant Ovarian Cancer

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E8: The Future of Oncology

S11 E9: Fungi, Facts, and Cancer Care: Exploring Medicinal Mushrooms

S11 E6: Finding the Heart of Oncology

S11 E7: Your Health Story in One Place

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Zanidatamab-hrii

Treatment Support Kit: Avutometinib and Defactinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Carboplatin and Docetaxel

Vinorelbine

Pemetrexed

Bevacizumab, Carboplatin, and Paclitaxel

Durvalumab and Bacillus Calmette-Guérin

Durvalumab and Tremelimumab

Durvalumab and FLOT

Durvalumab, Carboplatin, and Etoposide